胸肌前与胸肌后乳房再造术后疼痛及阿片类药物使用比较
单中心回顾性队列研究将73例胸肌前假体乳房再造患者按年龄和分期1:1匹配至胸肌后再造,最终纳入146例。胸肌前组术后疼痛评分、住院期间阿片类药物用量及住院时间均显著低于胸肌后组,多因素分析结果一致。
要点
- 胸肌前再造与更低的术后疼痛评分相关(多因素分析3.94 vs 5.25)。
- 胸肌前再造与更低的住院期间阿片类药物用量相关(多因素分析17.14 vs 63.03 mg OME)。
- 胸肌前再造与更短的住院时间相关(多因素分析21.36 vs 26.28 h)。
核心结论
- 乳腺癌切除术后胸肌前假体乳房再造较胸肌后再造显著降低术后疼痛、阿片类药物用量及住院时间。
主要发现
- 胸肌前组直接置入假体比例更高(84.9% vs 34.3%,p<0.001)。
- 胸肌前组初始假体填充量更高(401.53 mL vs 280.88 mL,p<0.001)。
- 胸肌前组术后疼痛评分显著更低(4.29 vs 5.44,p<0.001)。
- 胸肌前组住院期间阿片类药物用量显著更低(62.63 mg OME vs 98.84 mg OME,p=0.03)。
- 多因素分析中疼痛(3.94 vs 5.25,p<0.001)、阿片用量(17.14 mg OME vs 63.03 mg OME,p=0.03)及住院时间(21.36 vs 26.28 h,p=0.02)差异仍显著。
临床怎么用
- 对于适合假体乳房再造的患者,胸肌前入路可能有助于减少术后疼痛和阿片类药物使用并缩短住院时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prepectoral (PP) breast reconstruction is now commonly performed and minimizes dissection of the pectoralis major muscle. Data are lacking comparing the immediate postoperative recovery of these patients as compared with traditional subpectoral (SP) breast reconstruction. METHODS: From December 2015 to February 2017, 73 patients underwent PP prosthetic-based reconstruction at a single academic institution. PP cases were matched 1:1, by age and stage, to patients undergoing traditional SP reconstruction. Analysis of postoperative pain (visual analog scale) and opioid use (oral morphine equivalents, OME), was performed with both bi- and multivariate analyses. Additional outcomes explored included length of stay (LOS) and reconstructive intervention by plane of prosthetic reconstruction. RESULTS: A total of 146 patients were included in the final cohort. PP reconstruction was associated with higher rates of direct-to-implant reconstruction (84.9% vs. 34.3%, p <0.001) and higher rates of initial prosthetic fill (401.53 mL vs. 280.88 mL, p<0.001). Patients undergoing PP reconstruction had significantly reduced postoperative pain (4.29 vs. 5.44, p<0.001) and in-hospital opioid use (62.63 mg OME vs. 98.84 mg OME, p = 0.03) compared with SP patients. This result remained in multivariate analysis for both pain (3.94 vs. 5.25, p<0.001) and opioid use (17.14 mg OME vs. 63.03 mg OME, p = 0.03). Additionally, patients undergoing PP reconstruction had significantly reduced overall LOS on multivariate analysis (21.36 vs. 26.28 h, p = 0.02). CONCLUSION: Following mastectomy, PP breast reconstruction results in significantly reduced pain, opioid use, and hospital LOS compared with SP reconstruction.
引用
- Bozzuto LM, Bartholomew AJ, Tung S, et al. Decreased postoperative pain and opioid use following prepectoral versus subpectoral breast reconstruction after mastectomy: A retrospective cohort study: Pain after pre- versus subpectoral reconstruction. J Plast Reconstr Aesthet Surg. 2020. PMID: 33451949. doi:10.1016/j.bjps.2020.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。